USA - NASDAQ:EXOZ - US4618741098 - Common Stock
The current stock price of EXOZ is 14.52 USD. In the past month the price increased by 15.24%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.75 | 413.15B | ||
| AMGN | AMGEN INC | 15.73 | 185.19B | ||
| GILD | GILEAD SCIENCES INC | 15.53 | 157.81B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.09 | 111.66B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.12 | 76.88B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 906.47 | 60.60B | ||
| INSM | INSMED INC | N/A | 42.62B | ||
| NTRA | NATERA INC | N/A | 29.32B | ||
| BIIB | BIOGEN INC | 10.09 | 24.75B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.06 | 21.56B | ||
| INCY | INCYTE CORP | 16.18 | 20.29B | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | 33.17 | 13.75B |
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
EXOZYMES INC
750 Royal Oaks Dr
Monrovia California CALIFORNIA US
Employees: 31
Phone: 16264151488
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
The current stock price of EXOZ is 14.52 USD. The price decreased by -2.68% in the last trading session.
EXOZ does not pay a dividend.
EXOZ has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
EXOZYMES INC (EXOZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.69).
EXOZYMES INC (EXOZ) will report earnings on 2026-03-31.
You can find the ownership structure of EXOZYMES INC (EXOZ) on the Ownership tab.
ChartMill assigns a technical rating of 6 / 10 to EXOZ.
ChartMill assigns a fundamental rating of 1 / 10 to EXOZ. The financial health of EXOZ is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months EXOZ reported a non-GAAP Earnings per Share(EPS) of -1.69. The EPS decreased by -256.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -79.66% | ||
| ROE | -106.54% | ||
| Debt/Equity | 0.01 |